Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Sep 12;10(1):42.
doi: 10.1186/s40779-023-00480-w.

RARRES2's impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis

Quazi T H Shubhra  1   2
Affiliations
Comment

RARRES2's impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis

Quazi T H Shubhra. Mil Med Res. .
No abstract available

Keywords: Brain metastasis; Cancer; Lipid metabolism; Metabolic reprogramming; PTEN-mTOR-SREBP1 signaling; Retinoic acid receptor responder 2 (RARRES2).

PubMed Disclaimer

Conflict of interest statement

The author declares that there is no competing interests.

Comment on

References

    1. Li YQ, Sun FZ, Li CX, Mo HN, Zhou YT, Lv D, et al. RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer. Mil Med Res. 2023;10(1):34. - PMC - PubMed
    1. Guo K, Xiao N, Liu Y, Wang Z, Tóth J, Gyenis J, et al. Engineering polymer nanoparticles using cell membrane coating technology and their application in cancer treatments: opportunities and challenges. Nano Mater Sci. 2022;4(4):295–321. doi: 10.1016/j.nanoms.2021.12.001. - DOI
    1. Sirhan Z, Thyagarajan A, Sahu RP. The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer. Mil Med Res. 2022;9(1):39. - PMC - PubMed
    1. Ernst MC, Sinal CJ. Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab. 2010;21(11):660–667. doi: 10.1016/j.tem.2010.08.001. - DOI - PubMed
    1. Rennier K, Shin WJ, Krug E, Virdi G, Pachynski RK. Chemerin reactivates PTEN and suppresses PD-L1 in tumor cells via modulation of a novel CMKLR1-mediated signaling cascade. Clin Cancer Res. 2020;26(18):5019–5035. doi: 10.1158/1078-0432.CCR-19-4245. - DOI - PubMed